We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CHIN to accelerate development of new vaccines and therapies

CHIN to accelerate development of new vaccines and therapies

December 15, 2011
CenterWatch Staff

Seven universities, led by The University of Western Ontario, have been awarded a $600,000 catalyst grant from the Canadian Institutes of Health Research (CIHR) to create a national network to promote and enhance research on the body’s immune system. 

The CIHR Human Immunology Network (CHIN) will facilitate basic and clinical research and will help position Canada as a leader in the development of new vaccines and therapies for infectious diseases, allergies, HIV/AIDS, cancer, and transplantation.

Western will be joined by McGill, McMaster, the University of Toronto, the University of British Columbia, the University of Manitoba, and Dalhousie University. The Centre for Human Immunology at Western’s Schulich School of Medicine & Dentistry is the coordinating center.

"CHIN will position Canada as a world leader in human immunology and its translation to improve global health,” says CHIN principle investigator and executive director Quim Madrenas, chair of the department of microbiology and immunology at McGill. “From developing vaccines to discovering new therapies to treat autoimmune diseases and transplant rejection, from improving food and water safety to preparedness for emerging infections, CHIN will be an invaluable resource to the community.”

CHIN will act as a coordinating resource for investigators working in different aspects of the immune system to ensure that human immunology in Canada remains at the forefront of the international effort.

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Patient-phsyician-consultation

    Giving Patients Back Their Voice in Clinical Trials

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing